10-Q: CLS Holdings USA Reports Q3 2025 Results: Revenue Declines Amid Debt Reduction Efforts

CLS Holdings USA, Inc. reports a decrease in revenue for Q3 2025, but shows progress in reducing debt and improving operational efficiency.

Summary

• CLS Holdings USA, Inc. reported a 22% decrease in revenue for the three months ended February 28, 2025, with revenue totaling $3.85 million compared to $4.93 million in the same period last year.
• The decrease in revenue is attributed to lower sales at both the cannabis dispensary and in cannabis production, with dispensary revenue down 21% and production revenue down 23%.
• Cost of goods sold decreased by 17% to $2.31 million, but the gross margin decreased from 43.2% to 40% due to a write-off of $205,180 related to quality control issues.
• Selling, general, and administrative expenses decreased by 25% to $1.94 million due to cost-cutting efforts.
• The company reported a net loss of $278,880, a significant improvement from the $4.37 million net loss in the prior year, primarily due to debt restructuring and cost reductions.
• For the nine months ended February 28, 2025, revenue decreased by 16% to $12.82 million, and the net loss decreased by 81% to $1.19 million.
• The company is actively reducing its debt burden through settlements, restructurings, principal payments, and conversions of debt to common stock.
• CLS Holdings has a working capital deficit of $14.59 million, largely due to tax accruals under Section 280E of the Internal Revenue Code.
• The company generated positive cash flow from operating activities of $321,052 for the nine months ended February 28, 2025.
• The company plans to build a cannabis consumption lounge and outdoor patio area attached to the Oasis dispensary, with an estimated capital expenditure of $500,000 to $1,000,000.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue is down, the company is making progress in reducing debt and improving operational efficiency. The going concern qualification and working capital deficit are concerns, but the positive cash flow from operations is encouraging.

Positives

• Net loss significantly decreased due to debt restructuring and cost reductions.
• Selling, general, and administrative expenses decreased due to cost-cutting efforts.
• The company is actively reducing its debt burden.
• The company generated positive cash flow from operating activities.

Negatives

• Revenue decreased by 22% for the three months ended February 28, 2025.
• Gross margin decreased from 43.2% to 40% due to a write-off of $205,180 related to quality control issues.
• The company has a working capital deficit of $14.59 million, largely due to tax accruals under Section 280E of the Internal Revenue Code.

Risks

• The company's auditors have included a going concern qualification in their audit report.
• The company has a significant working capital deficit.
• The company's ability to use net operating losses to offset Section 280E tax expenses is uncertain.
• The effects of climate change could adversely affect the quantity and quality of crops and the cost and availability of energy to dispensary operations.

Future Outlook

The company intends to continue efforts to reduce its debt burden and focus on operational activities to improve cash flow, and plans to build a cannabis consumption lounge and outdoor patio area attached to the Oasis dispensary.

Industry Context

The report reflects the challenges and opportunities within the cannabis industry, including the impact of regulations like Section 280E and the need for cost management and debt reduction.

Comparison to Industry Standards

• It is difficult to compare CLS Holdings directly to industry standards due to its unique business model and specific market focus.
• Comparable companies in the cannabis industry include vertically integrated operators like Curaleaf, Trulieve, and Green Thumb Industries, but their scale and geographic diversification differ significantly.
• CLS Holdings' focus on the Nevada market and its extraction technology may offer a competitive advantage, but it also faces challenges related to market saturation and regulatory hurdles.
• The company's debt reduction efforts are crucial for improving its financial stability and attracting investors, as many cannabis companies struggle with profitability and access to capital.

Related Party Transactions

• The company acquired and cancelled 1,125,000 shares of common stock from a board member at a cost of $40,000.
• The company issued PN9, a note payable to a related party, in the principal amount of $2,600,000.
• The company issued PN10, a note payable to a related party, in the principal amount of $150,000.
• The company issued PN11, a note payable to a related party, in the principal amount of $150,000.
• The company issued PN12, a note payable to a related party, in the principal amount of $300,000.
• The company issued PN13, a note payable to a related party, in the principal amount of $300,000.
• The company issued PN14, a note payable to a related party, in the principal amount of $300,000.
• The company issued PN16, a note payable to a related party, in the principal amount of $125,000.

Stakeholder Impact

• Shareholders: The decrease in revenue may be concerning, but the improved net loss and debt reduction efforts are positive signs.
• Employees: Cost-cutting efforts may impact employees, but the company's focus on operational efficiency could lead to long-term stability.
• Customers: The company's focus on product quality and customer service is important for maintaining customer loyalty.
• Creditors: The company's debt reduction efforts are positive for creditors, as it reduces the risk of default.

Next Steps

• Continue efforts to reduce debt burden.
• Focus on operational activities to improve cash flow.
• Build a cannabis consumption lounge and outdoor patio area attached to the Oasis dispensary.

Key Dates

Keywords

cannabis, CLS Holdings, financial results, debt reduction, revenue, net loss, EBITDA, dispensary, extraction, Nevada